Biomark Diagnostics Inc. (FRA:20B)
Germany · Delayed Price · Currency is EUR 0.2760
+0.0040 (1.47%)
At close: Jan 30, 2026
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of €29 million as of January 30, 2026. Its market cap has increased by 190.12% in one year.
Market Cap
29.00M
Enterprise Value
28.55M
Revenue
75.52K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.28
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has increased from 28.50M to 29.00M, an increase of 1.79%. That is a compound annual growth rate of 0.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 29.00M | -10.97% |
| Dec 30, 2025 | 32.58M | 228.85% |
| Dec 30, 2024 | 9.91M | -19.08% |
| Dec 29, 2023 | 12.24M | 23.53% |
| Dec 30, 2022 | 9.91M | -23.89% |
| Dec 30, 2021 | 13.02M | 134.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 40.70M |
| U.C.A. Aktiengesellschaft | 40.20M |
| OTRS AG | 36.22M |
| edding AG | 35.48M |
| Readcrest Capital AG | 32.13M |
| Weng Fine Art AG | 29.08M |
| Rubean AG | 27.29M |
| Hyrican Informationssysteme Aktiengesellschaft | 22.80M |